دورية أكاديمية

Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells

التفاصيل البيبلوغرافية
العنوان: Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells
المؤلفون: Ezhilarasan, Devaraj
المصدر: Experimental Biology and Medicine ; volume 245, issue 16, page 1504-1512 ; ISSN 1535-3702 1535-3699
بيانات النشر: Frontiers Media SA
سنة النشر: 2020
المجموعة: Frontiers (Publisher - via CrossRef)
الوصف: Portal hypertension is one of the most important cirrhosis-associated complications of chronic liver disease, leading to significant morbidity and mortality. After chronic liver injury, hepatic stellate cells reside in the perisinusoidal space activted and acquire a myofibroblast-like phenotype. The activated hepatic stellate cells act as both sources as well as the target for a potent vasoconstrictor endothelin-1. Activation of hepatic stellate cells plays a vital role in the onset of cirrhosis by way of increased extracellular matrix production and the enhanced contractile response to vasoactive mediators such as endothelin-1. In fibrotic/cirrhotic liver, activated hepatic stellate cells produce endothelin-1 leading to an imbalance between pro and antifibrotic factors responsible for enormous extracellular matrix synthesis. Thus, extracellular matrix deposition in the perisinusoidal space further augments liver stiffness and elevates the vascular tone and portal hypertension. Portal hypertension is a complex process modulated by several cell types like hepatic stellate cells, liver sinusoidal endothelial cells, Kupffer cells, injured hepatocytes, immune cells, and biliary epithelial cells. Therefore, targeting a single cell type may not be useful for regression of cirrhosis and portal hypertension. Nevertheless, numerous findings indicate that functionally liver sinusoidal endothelial cells and hepatic stellate cells closely regulate the sinusoidal blood flow via synthesis of several vasoactive molecules including endothelin-1, and hence targeting these cells with novel pharmacological agents may offer promising results. Impact statement Portal hypertension is pathologically defined as increase of portal venous pressure, mainly due to chronic liver diseases such as fibrosis and cirrhosis. In fibrotic liver, activated hepatic stellate cells increase their contraction in response to endothelin-1 (ET-1) via autocrine and paracrine stimulation from liver sinusoidal endothelial cells and injured hepatocytes. ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1177/1535370220949148
الإتاحة: https://doi.org/10.1177/1535370220949148Test
حقوق: http://journals.sagepub.com/page/policies/text-and-data-mining-licenseTest
رقم الانضمام: edsbas.5CA9BD4B
قاعدة البيانات: BASE